Biogen
Company
A pharmaceutical company that manufactures Aducanumab, a highly discussed monoclonal antibody targeting amyloid for Alzheimer's treatment.
Mentioned in 4 videos
Videos Mentioning Biogen
164 - Diagnosing, preventing, & treating Alzheimer’s disease, & life lessons from dementia patients
Peter Attia MD
A pharmaceutical company that manufactures Aducanumab, a highly discussed monoclonal antibody targeting amyloid for Alzheimer's treatment.
John Abramson: Big Pharma | Lex Fridman Podcast #263
Lex Fridman
The pharmaceutical company that developed Aduhelm, which was controversially approved by the FDA despite negative advisory committee vote and trial outcomes.
E89: GDP growth negative in Q2, $SHOP layoffs, Alzheimer's fraud, Ginkgo acquires Zymergen & more
All-In Podcast
Developed a drug targeting amyloid beta plaques for Alzheimer's, which received FDA approval despite questionable data.
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
All-In Podcast
Pharmaceutical company that developed Aducanumab, a controversial Alzheimer's drug approved by the FDA.